ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO374

Insulin and Glucose Tolerance Assessment in Guanylyl Cyclase/Natriuretic Peptide Receptor-A Gene-Targeted Mutant Mice

Session Information

Category: Diabetic Kidney Disease

  • 701 Diabetic Kidney Disease: Basic


  • Neelamegam, Kandasamy, Tulane University School of Medicine, New Orleans, Louisiana, United States
  • Pandey, Kailash Nath, Tulane University School of Medicine, New Orleans, Louisiana, United States

Atrial natriuretic peptide (ANP), acting through the guanylyl cyclase/natriuretic peptide receptor-A (GC-A/NPRA), is pivotal in regulating blood pressure and cardiac homeostasis. Ablation of Npr1 (encoding NPRA) in mice exhibits hypertension and provokes congestive heart failure; however, the underlying mechanisms are not yet precisely determined. The objective of this study was to investigate whether Npr1 plays a critical role in regulating glucose homeostasis.


The adult male (14-18 wk) Npr1 gene-knockout haplotype (Npr1+/-, 1-copy), wild-type (Npr1+/+, 2-copy), and gene-duplicated (Npr1+ +/+ +, 4-copy) mice were fasted overnight (16 h) and given free access to water. The mice were administrated with glucose both orally and intraperitoneally (2 g/kg body weight) to determine the oral glucose tolerance test (OGTT) and intraperitoneal glucose tolerance test (IPGTT). For the insulin tolerance test (ITT), mice were also fasted for 16 h and then received an ip-injection of 1.0 UI/kg of insulin. Blood glucose levels were determined by performing tail bleeds at 0, 15, 30, 60, 90, and 120 min using AlphaTRAK. The non-invasive tail-cuff method determined systolic blood pressure (SBP).


The results showed that administration of glucose resulted in a greater increase in blood glucose levels at 120 mins in 1-copy male mice (OGTT: 237 ± 5 mg/dL, IPGT: 246 ± 6 mg/dL, ITT; 239 ± 7 mg/dL) than 2-copy male (OGTT: 131 ± 3 mg/dL, IPGT: 126 ± 6 mg/dL, ITT; 127 ± 6 mg/dL), respectively. The blood glucose was also significantly lower in 4-copy mice (OGTT: 113 ± 5 mg/dL, IPGT: 108 ± 7 mg/dL, ITT; 107 ± 3 mg/dL) than in 2-copy mice. SBP was significantly greater in 1-copy mice (130 ± 4 mmHg) than in 2-copy mice (100 ± 3 mmHg) and significantly lower in 4-copy mice (90 ± 2) in 2-copy mice. The increase in plasma glucose levels were significantly lower in OGTT than in IPGTT.


NPRA markedly prevented a steep rise in blood glucose levels after glucose challenge and ameliorated glucose intolerance and insulin resistance in 2-copy and 4-copy mice than 1-copy mice. The results suggest that NPRA signaling predisposes to arterial pressure, hyperglycemia, and insulin resistance, thus Npr1 gene might regulate blood glucose homeostasis. Supported by NIH grant DK133833.


  • NIDDK Support